Powered by WebAds

Thursday, November 01, 2012

An Israeli company has gotten the go-ahead from European authorities to manufacture a universal flu vaccine. This would obviate the need to develop a new vaccine for each flu season.
BiondVax Pharmaceuticals recently announced that it passed an intensive two-day QP GMP audit – giving it a green light to advance clinical development of its universal flu vaccine, M-001, in the EU. This demanding certification is a requirement for companies intending to manufacture a clinical grade product for human trials anywhere in Europe.


BiondVax, an innovative biopharmaceutical company developing a flu vaccine designed to provide multi-season and multi-strain protection against most human influenza virus strains, also announced that it will conduct collaborative studies with MonoSol Rx located in New Jersey, to investigate the activity of M-001 when formulated utilizing MonoSol’s technology for administration by mouth. 
In case you're wondering, they're located in Nes Ziona, which is inside the 1949 armistice lines. I wonder how many Euromorons will choose to get the flu anyway rather than using a product from an Israeli company. Heh.



At 2:09 PM, Blogger HaDaR said...

Let me give you ANOTHER perspective....

Imagine the heavy and blood-spilling, R"L, anti-Jewish reaction in case of a widespread and murderous flu epidemic AFTER they use Israeli vaccines...


THAT is the Torah blessing for our People.


Post a Comment

Links to this post:

Create a Link

<< Home